The Vireo Advisors blog brings you the latest news and developments in safe, sustainable and bio-based materials and products including novel foods and sustainable nanomaterials.
Regulating the Future of Food Conference November 23-24, 2023
Dr. Kimberly Ong, safety and regulatory consultant at Vireo Advisors, LLC, exchanged ideas with researchers and regulators from around the world as they worked together to make regulatory systems more efficient for commercialization of cultivated meat and seafood and precision fermented foods, while still holding a high bar for safety.
FSIS has issued its policy for cultured meat and poultry
The US Department of Agriculture Food Safety and Inspection Service (USDA-FSIS) has announced details of their sampling program for cell-cultured meat and poultry products.
Vireo and New Harvest publish regulatory and governmental perspectives on cultured meat safety research priorities
Vireo Advisors and New Harvest are excited to announce that we have published the outcomes of Phase II of the Cultured Meat Safety Initiative (CMSI). The paper catalogues key findings from an extensive series of interviews and workshops held with regulatory and governmental scientists worldwide.
Vireo Advisors, LLC Joins Cellular Agriculture Canada initiative with New Harvest
Cellular Agriculture Canada has been re-launched as a multi-stakeholder coalition led by New Harvest Canada joined by Vireo Advisors, LLC. The mandate of the group is the directive that Canada can capitalize on the global movement to achieve a net-zero economy by leveraging its strengths in the emerging field of cellular agriculture.
USDA responsibilities in establishments producing cultured meat
A new USDA directive establishes inspection requirements for companies producing cultured meat which will be jointly overseen by the FDA and FSIS. Products will be subject to the same FSIS regulatory requirements and oversight authority as meat and poultry products derived from animal slaughter, but labels applied to these foods are not eligible for generic approval.